The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

• Hypertension is a major risk factor for arteriosclerotic vascular disease. Despite intensive
antihypertensive Intervention, the risk of cardiovascular disease has not declined …

Hypertension and certain alterations in serum lipoproteins such as a decrease in high
density lipoprotein-cholesterol (HDL-C), an increase in low density lipoprotein-cholesterol …

The clinical evaluation of the patient with dyslipoproteinemia requires a thorough appraisal
of present and past medical history, a review of systems, and physical examination. Any …

The relationship of beta-blocker drug use to plasma low density lipoprotein-cholesterol (LDL-
C), lipoprotein mass distribution,(LDL, S f 0–12), intermediate density lipoproteins (IDL, S f …

• Proves that the majority of cases of stroke, heart attack, and hypertension can easily be
prevented by maintaining the proper ratio of potassium to sodium in the diet.• Updated with …

A new polymeric matrix technology provides a sustained‐release formulation of diltiazem
hydrochloride (diltiazem SR) suitable for once‐daily therapy. The efficacy and safety of …

The past 10 to 20 years have witnessed a substantial improvement in the outlook of a variety
of cardiovascular disorders, with a corresponding improvement in life expectancy. To a …

Fourteen male patients (mean age±SD, 52±11 years) with a history of hypertension (systolic
blood pressure, 148±10 mm Hg; diastolic blood pressure, 99±2 mm Hg) were enrolled in a …

T HAS LONG BEEN recognized that essential hypertension is a powerful cardiovascular risk
factor. This review will address the risk of both coronary artery disease (CAD) and …